Highlights Insulet Corporation

Equities

PODD

US45784P1012

Market Closed - Nasdaq Other stock markets 21:00:00 18/06/2024 BST			5-day change	1st Jan Change
196.4 ^USD	-1.01%		-2.13%	-9.48%

01:16pm	Insulet Launches Omnipod 5 Tubeless Insulin System in the UK, Netherlands	MT
06-17	Insulet Insider Sold Shares Worth $299,940, According to a Recent SEC Filing	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Insulet Launches Omnipod 5 Tubeless Insulin System in the UK, Netherlands	12:16pm	MT
Insulet Shares Rise Despite Blue Orca's Short Position	05-14	MT
Insulet misses first-quarter profit estimates as marketing costs weigh	05-09	RE
Insulet Q1 Earnings, Revenue Rise; 2024 Revenue Growth Boosted	05-09	MT
Earnings Flash (PODD) INSULET CORPORATION Reports Q1 Revenue $441.7M, vs. Street Est of $423.5M	05-09	MT
Insulet Raises Full Year 2024 Revenue Growth Range to 14%-18%, vs Prior View of 12%-17%; Sees Q2 Revenue Growth of 15%-18%	05-09	MT
Insulet Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Insulet Corporation Provides Revenue Guidance for the Second Quarter Ending June 30, 2024	05-09	CI
Insulet Corporation Revises Earnings Guidance for the Year Ending December 31, 2024	05-09	CI
US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	03-20	MT
3M Board Approves Healthcare Unit Spinoff -- Update	03-08	DJ
Insulet Corporation Presents Positive Results from its First Randomized Controlled Trial Showing Improved Glycemic and Patient-Reported Outcomes in Type 1 Diabetes with the Omnipod 5 Automated Insulin Delivery System (Omnipod 5)	03-08	CI
Insulet Corporation to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17Th International Conference on Advanced Technologies & Treatments for Diabetes	03-05	CI
Stocks in motion: Alphabet drops as Microsoft signs another AI partnership	02-26
Insulet forecasts weak annual revenue growth; shares drop	02-22	RE
Insulet Q4 Adjusted Earnings, Revenue Increase; Q1, 2024 Revenue Outlook Set	02-22	MT
Earnings Flash (PODD) INSULET CORPORATION Posts Q4 EPS $1.40, vs. Street Est of $0.66	02-22	MT
Earnings Flash (PODD) INSULET CORPORATION Reports Q4 Revenue $509.8M, vs. Street Est of $461.1M	02-22	MT
Insulet Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-22	CI
Insulet beats quarterly profit estimates on strong demand for insulin pumps	02-22	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Insulet Corporation

Equities

PODD

US45784P1012

Highlights

Filters